Hostname: page-component-cd9895bd7-7cvxr Total loading time: 0 Render date: 2024-12-27T03:15:21.245Z Has data issue: false hasContentIssue false

Transcatheter creation of a pulmonary artery to left atrial fenestration in a failing Fontan circulation using the Atrial Flow Regulator (AFR)

Published online by Cambridge University Press:  26 March 2021

Emma Pascall*
Affiliation:
Department of Congenital Heart Disease, Evelina London Children’s Hospital, Guy’s & St Thomas NHS Foundation Trust, London, UK
Matthew I. Jones
Affiliation:
Department of Congenital Heart Disease, Evelina London Children’s Hospital, Guy’s & St Thomas NHS Foundation Trust, London, UK
Alexandra Savis
Affiliation:
Department of Congenital Heart Disease, Evelina London Children’s Hospital, Guy’s & St Thomas NHS Foundation Trust, London, UK
Eric Rosenthal
Affiliation:
Department of Congenital Heart Disease, Evelina London Children’s Hospital, Guy’s & St Thomas NHS Foundation Trust, London, UK
Shakeel A. Qureshi
Affiliation:
Department of Congenital Heart Disease, Evelina London Children’s Hospital, Guy’s & St Thomas NHS Foundation Trust, London, UK
*
Author for correspondence: Dr Emma Pascall, Department of Congenital Heart Disease, Evelina London Children’s Hospital, Guy’s & St Thomas NHS Foundation Trust, London, UK. Tel: +44 02071887188; Fax: 02071884556. E-mail: [email protected]

Abstract

Transcatheter creation of an interatrial communication using the Occlutech Atrial Flow Regulator Device for pulmonary hypertension or heart failure is well described. We report a case of an 8-year-old boy with a failing Fontan circulation, in whom the Atrial Flow Regulator was used to successfully create a fenestration between the pulmonary artery and left atrium, improving his clinical condition.

Type
Brief Report
Copyright
© The Author(s), 2021. Published by Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Gewillig, M The Fontan circulation. Heart 2005; 91: 839846.CrossRefGoogle ScholarPubMed
Wilson, J, Russell, J, Williams, W, et al. Fenestration of the Fontan circuit as treatment for plastic bronchitis. Pediatr Cardiol 2005; 26: 717719.CrossRefGoogle ScholarPubMed
d’Udekem, Y, Iyengar, AJ, Galati, JC, et al. Redefining expectations of long-term survival after the Fontan procedure: twenty-five years of follow-up from the entire population of Australia and New Zealand. Circulation 2014; 130 (11 Suppl 1): S32S38.CrossRefGoogle ScholarPubMed
Gibb, E, Blount, R, Lewis, N, et al. Management of plastic bronchitis with topical tissue-type plasminogen activator. Pediatrics 2012; 130: e446e450.CrossRefGoogle ScholarPubMed
Lehner, A, Schulze-Neick, I, Haas, NA Creation of a defined and stable Fontan fenestration with the new Occlutech Atrial Flow Regulator (AFR®). Cardiol Young 2018; 28: 10621066.CrossRefGoogle ScholarPubMed
Rupp, S, Schieke, C, Kerst, G, et al. Creation of a transcatheter fenestration in children with failure of Fontan circulation: focus on extracardiac conduit connection. Catheter Cardiovasc Interv 2015; 86: 11891194.10.1002/ccd.26042CrossRefGoogle ScholarPubMed
Vyas, H, Driscoll, DJ, Cabalka, AK, Cetta, F, Hagler, DJ Results of transcatheter Fontan fenestration to treat protein losing enteropathy. Catheter Cardiovasc Interv 2007; 69: 584589.CrossRefGoogle ScholarPubMed
Dąbrowska-Kugacka, A, Ciećwierz, D, Żuk, G, et al. Atrial flow regulator for severe drug resistant pulmonary arterial hypertension after congenital heart defect correction. Cardiol J 2019; 26: 102104.CrossRefGoogle ScholarPubMed
Sonawane, BS, Sivakumar, K Transcatheter reduction in size of large undesirable fenestrations following extracardiac conduit Fontan surgery with off-label use of Occlutech atrial flow regulator. Ann Pediatr Cardiol 2020; 13: 260263.Google ScholarPubMed
Manuri, L, Calaciura, RE, De Zorzi, A, et al. Atrial flow regulator for failing Fontan circulation: an initial European experience. Interact CardioVasc Thorac Surg 2018; 27: 761764.CrossRefGoogle Scholar